Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by bluemoons20on Feb 14, 2021 10:16pm
266 Views
Post# 32566703

price history

price history looking at the price history,  the big  jumps  in day over day price come on days with at least  11 or 12  million shares.

The last  week  , volume has been around 5 million per day.  In a lot of stocks  , this would be great volume  but it seems for  VPT  it is not enough.

I have not been a shareholder for years like some of you.  Given the  noted news release,  where is the actual  sales of the product 4 years later, if they received some sort of approval  way back.

They are now  expanding their scope to provide idagnostics for dogs  but the market for  people has not yet been penetrated.  Though it sounds good to be potentially expanding the market,  how does this bode for the stock price??   Are they changing focus in mid stream?  Even with COVID  , hospitals are still operating  and could potentially use thie tool  with COVID patients since there is some talk of  organ damage associated with   COVID itself.

Can someone  give me  an idea of  where  the product actually is relative to getting actual  sales and introduction??

Thanks  for any information.

<< Previous
Bullboard Posts
Next >>